Economic evaluation of denosumab compared with zoledronic acid in patients with hormone-refractory prostate cancer with bone metastases.
A. P. Yu
Employment or Leadership Position - Analysis Group
M. Namjoshi
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
J. Xie
Employment or Leadership Position - Analysis Group
K. Parikh
Employment or Leadership Position - Analysis Group
E. Q. Wu
Employment or Leadership Position - Analysis Group
A. Guo
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
K. W. Culver
Employment or Leadership Position - Novartis
Stock Ownership - Novartis